Works matching IS 03407004 AND DT 2022 AND VI 71 AND IP 11

Results: 21

Correction to: Functional antigen processing and presentation mechanism as a prerequisite factor of response to treatment with dendritic cell vaccines and anti-PD-1 in preclinical murine LLC1 and GL261 tumor models.
Published in:
2022
By:
- Žilionytė, Karolina;
- Bagdzevičiūtė, Ugnė;
- Mlynska, Agata;
- Urbštaitė, Elena;
- Paberalė, Emilija;
- Dobrovolskienė, Neringa;
- Krasko, Jan Aleksander;
- Pašukonienė, Vita
Publication type:
Correction Notice
Gene expression profile of high PD-L1 non-small cell lung cancers refractory to pembrolizumab.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2791, doi. 10.1007/s00262-022-03206-4
By:
- Talb, Jamila;
- Takam Kamga, Paul;
- Mayenga, Marie;
- Costantini, Adrien;
- Julié, Catherine;
- Dumenil, Coraline;
- Dumoulin, Jennifer;
- Ouaknine, Julia;
- Giraud, Violaine;
- Dujon, Cécile;
- Azarian, Reza;
- Glaser, Claire;
- Emile, Jean-François;
- Giroux Leprieur, Etienne
Publication type:
Article
Clinical and molecular correlates of response to immune checkpoint blockade in urothelial carcinoma with liver metastasis.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2815, doi. 10.1007/s00262-022-03204-6
By:
- Yoshida, Takashi;
- Ohe, Chisato;
- Ito, Katsuhiro;
- Takada, Hideaki;
- Saito, Ryoichi;
- Kita, Yuki;
- Sano, Takeshi;
- Tsuta, Koji;
- Kinoshita, Hidefumi;
- Kitamura, Hiroshi;
- Nishiyama, Hiroyuki;
- Kobayashi, Takashi
Publication type:
Article
Establishment of a mechanism-based in vitro coculture assay for evaluating the efficacy of immune checkpoint inhibitors.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2777, doi. 10.1007/s00262-022-03201-9
By:
- Kim, Myeong Joon;
- Hong, Kyeong Hee;
- Lee, Bo Ryeong;
- Ha, Sang-Jun
Publication type:
Article
Role of the cGAS-STING pathway in regulating the tumor-immune microenvironment in dMMR/MSI colorectal cancer.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2765, doi. 10.1007/s00262-022-03200-w
By:
- Kaneta, Akinao;
- Nakajima, Shotaro;
- Okayama, Hirokazu;
- Matsumoto, Takuro;
- Saito, Katsuharu;
- Kikuchi, Tomohiro;
- Endo, Eisei;
- Ito, Misato;
- Mimura, Kosaku;
- Kanke, Yasuyuki;
- Saito, Motonobu;
- Saze, Zenichiro;
- Fujita, Shotaro;
- Sakamoto, Wataru;
- Onozawa, Hisashi;
- Momma, Tomoyuki;
- Ohki, Shinji;
- Kono, Koji
Publication type:
Article
The soluble form of CD160 acts as a tumor mediator of immune escape in melanoma.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2731, doi. 10.1007/s00262-022-03199-0
By:
- Gauci, Marie-Léa;
- Giustiniani, Jérôme;
- Lepelletier, Clémence;
- Garbar, Christian;
- Thonnart, Nicolas;
- Dumaz, Nicolas;
- Foussat, Arnaud;
- Lebbé, Céleste;
- Bensussan, Armand;
- Marie-Cardine, Anne
Publication type:
Article
Serial interferon-gamma release assay in lung cancer patients receiving immune checkpoint inhibitors: a prospective cohort study.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2757, doi. 10.1007/s00262-022-03198-1
By:
- Fujita, Kohei;
- Elkington, Paul;
- Redelman-Sidi, Gil;
- Kanai, Osamu;
- Yamamoto, Yuki;
- Imakita, Takuma;
- Okamura, Misato;
- Nakatani, Koichi;
- Mio, Tadashi
Publication type:
Article
Tumor-derived exosomes drive pre-metastatic niche formation in lung via modulating CCL1<sup>+</sup> fibroblast and CCR8<sup>+</sup> Treg cell interactions.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2717, doi. 10.1007/s00262-022-03196-3
By:
- Wang, Ming;
- Qin, Zhongyu;
- Wan, Jiajia;
- Yan, Yan;
- Duan, Xixi;
- Yao, Xiaohan;
- Jiang, Ziming;
- Li, Wenqing;
- Qin, Zhihai
Publication type:
Article
Chimeric antigen receptor clustering via cysteines enhances T-cell efficacy against tumor.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2801, doi. 10.1007/s00262-022-03195-4
By:
- Wang, Yuedi;
- Gao, Yiyuan;
- Niu, Congyi;
- Wang, Bo;
- Zhao, Shushu;
- Roex, Gils;
- Qian, Jiawen;
- Qie, Jingbo;
- Chen, Lin;
- Yi, Chenhe;
- Anguille, Sébastien;
- Liu, Jie;
- Luo, Feifei;
- Chu, Yiwei
Publication type:
Article
Prognostic significance of NY-ESO-1 antigen and PIGR expression in esophageal tumors of CHP-NY-ESO-1-vaccinated patients as adjuvant therapy.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2743, doi. 10.1007/s00262-022-03194-5
By:
- Nagata, Yasuhiro;
- Kageyama, Shinichi;
- Ishikawa, Takeshi;
- Kokura, Satoshi;
- Okayama, Tetsuya;
- Abe, Tetsuya;
- Murakami, Masahiko;
- Otsuka, Koji;
- Ariyoshi, Tomotake;
- Kojima, Takashi;
- Taniguchi, Ken;
- Kobayashi, Shinichiro;
- Shimada, Hideaki;
- Yajima, Satoshi;
- Suzuki, Takashi;
- Hirano, Satoshi;
- Tsuchikawa, Takahiro;
- Shichinohe, Toshiaki;
- Ueda, Shugo;
- Kanetaka, Kengo
Publication type:
Article
CXCL9-modified CAR T cells improve immune cell infiltration and antitumor efficacy.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2663, doi. 10.1007/s00262-022-03193-6
By:
- Tian, Yonggui;
- Wen, Chunli;
- Zhang, Zhen;
- Liu, Yanfen;
- Li, Feng;
- Zhao, Qitai;
- Yao, Chang;
- Ni, Kaiyuan;
- Yang, Shengli;
- Zhang, Yi
Publication type:
Article
Functional antigen processing and presentation mechanism as a prerequisite factor of response to treatment with dendritic cell vaccines and anti-PD-1 in preclinical murine LLC1 and GL261 tumor models.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2691, doi. 10.1007/s00262-022-03190-9
By:
- Žilionytė, Karolina;
- Bagdzevičiūtė, Ugnė;
- Mlynska, Agata;
- Urbštaitė, Elena;
- Paberalė, Emilija;
- Dobrovolskienė, Neringa;
- Krasko, Jan Aleksander;
- Pašukonienė, Vita
Publication type:
Article
Camrelizumab combined with apatinib and S-1 as second-line treatment for patients with advanced gastric or gastroesophageal junction adenocarcinoma: a phase 2, single-arm, prospective study.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2597, doi. 10.1007/s00262-022-03174-9
By:
- Jing, Chao;
- Wang, Junyun;
- Zhu, Mingyue;
- Bai, Zhigang;
- Zhao, Baoyi;
- Zhang, Jun;
- Yin, Jie;
- Yang, Xiaobao;
- Liu, Zongzhi;
- Zhang, Zhongtao;
- Deng, Wei
Publication type:
Article
OIT3 mediates macrophage polarization and facilitates hepatocellular carcinoma progression.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2677, doi. 10.1007/s00262-022-03188-3
By:
- Yang, Shuai;
- Zhang, Jiangang;
- Xu, Yanquan;
- Wang, Jingchun;
- Zhao, Huakan;
- Lei, Juan;
- Zhou, Yu;
- Chen, Yu;
- Wu, Lei;
- Zhou, Mingyue;
- Zheng, Lu;
- Ji, Xiaohui;
- Li, Yongsheng
Publication type:
Article
Lenvatinib plus pembrolizumab for systemic therapy-naïve and -experienced unresectable hepatocellular carcinoma.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2631, doi. 10.1007/s00262-022-03185-6
By:
- Wu, Chi-Jung;
- Lee, Pei-Chang;
- Hung, Ya-Wen;
- Lee, Chieh-Ju;
- Chi, Chen-Ta;
- Lee, I-Cheng;
- Hou, Ming-Chih;
- Huang, Yi-Hsiang
Publication type:
Article
Evaluation of the efficacy and safety of TAS0313 in adults with recurrent glioblastoma.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2703, doi. 10.1007/s00262-022-03184-7
By:
- Narita, Yoshitaka;
- Okita, Yoshiko;
- Arakawa, Yoshiki
Publication type:
Article
Epstein-Barr virus-induced ectopic CD137 expression helps nasopharyngeal carcinoma to escape immune surveillance and enables targeting by chimeric antigen receptors.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2583, doi. 10.1007/s00262-022-03183-8
By:
- Prasad, Mukul;
- Ponnalagu, Sashigala;
- Zeng, Qun;
- Luu, Khang;
- Lang, Si Min;
- Wong, Hiu Yi;
- Cheng, Man Si;
- Wu, Meihui;
- Mallilankaraman, Karthik;
- Sobota, Radoslaw Mikolaj;
- Lim, Yan Ting;
- Wang, Loo Chien;
- Goh, Chuan Keng;
- Tay, Kai Xun Joshua;
- Loh, Kwok Seng;
- Wang, Cheng-I.;
- Lee, Wen-Hsien;
- Goh, Boon Cher;
- Lim, Chwee Ming;
- Schwarz, Herbert
Publication type:
Article
Evolution of bone metastases in patients receiving at least three months of checkpoint inhibitors.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2609, doi. 10.1007/s00262-022-03180-x
By:
- Gefard-Gontier, E.;
- Markich, R.;
- Zysman, M.;
- Veillon, R.;
- Daste, A.;
- Domblides, C.;
- Sionneau, B.;
- Gross-Goupil, M.;
- Lefort, F.;
- Prey, S.;
- Dutriaux, C.;
- Gerard, E.;
- Dousset, L.;
- Pham-Ledard, A.;
- Beylot-Barry, M.;
- Schaeverbeke, T.;
- Kostine, M.
Publication type:
Article
The expression of PD-1 ligand 1 on macrophages and its clinical impacts and mechanisms in lung adenocarcinoma.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2645, doi. 10.1007/s00262-022-03187-4
By:
- Shinchi, Yusuke;
- Ishizuka, Shiho;
- Komohara, Yoshihiro;
- Matsubara, Eri;
- Mito, Remi;
- Pan, Cheng;
- Yoshii, Daiki;
- Yonemitsu, Kimihiro;
- Fujiwara, Yukio;
- Ikeda, Koei;
- Tamada, Koji;
- Sakagami, Takuro;
- Suzuki, Makoto
Publication type:
Article
Tafasitamab mediates killing of B-cell non-Hodgkin's lymphoma in combination with γδ T cell or allogeneic NK cell therapy.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2829, doi. 10.1007/s00262-022-03165-w
By:
- Her, Jung Hyun;
- Pretscher, Dominik;
- Patra-Kneuer, Maria;
- Schanzer, Juergen;
- Cho, Sung Yoo;
- Hwang, Yu Kyeong;
- Hoeres, Timm;
- Boxhammer, Rainer;
- Heitmueller, Christina;
- Wilhelm, Martin;
- Steidl, Stefan;
- Endell, Jan
Publication type:
Article
Altered immunity to microbiota, B cell activation and depleted γδ/resident memory T cells in colorectal cancer.
Published in:
Cancer Immunology, Immunotherapy, 2022, v. 71, n. 11, p. 2619, doi. 10.1007/s00262-021-03135-8
By:
- Noble, Alistair;
- Pring, Edward T.;
- Durant, Lydia;
- Man, Ripple;
- Dilke, Stella M.;
- Hoyles, Lesley;
- James, Steve A.;
- Carding, Simon R.;
- Jenkins, John T.;
- Knight, Stella C.
Publication type:
Article